Role of the lymphotoxin/LIGHT system in the development and maintenance of reticular networks and vasculature in lymphoid tissues

Frontiers in Immunology

Volumn 5, Issue FEB, 2014, Pages

  Lu, Theresa T ^a,b   Browning, Jeffrey L ^c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fibroblastic reticular cells; Follicular dendritic cell; High endothelial venules; Lymphotoxin beta receptor; Reactive lymph node; Reticular stroma

Indexed keywords

CD11 ANTIGEN; CD34 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; CXCL13 CHEMOKINE; DECOY RECEPTOR 3; HERPESVIRUS ENTRY MEDIATOR; HERPESVIRUS ENTRY MEDIATOR LIGAND; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOTOXIN; LYMPHOTOXIN BETA RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; OVALBUMIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANGIOGENESIS; CELL DIFFERENTIATION; CHRONIC INFLAMMATION; FIBROBLAST; FIBROSIS; FOLLICULAR DENDRITIC CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; INFECTION; LYMPH NODE; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHOID ORGAN; LYMPHOID TISSUE; MESENCHYMAL STEM CELL; METASTASIS; NEOPLASM; RETICULOENDOTHELIAL SYSTEM; RETICULUM CELL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VASCULARIZATION; VENULE; VIRUS INFECTION;

EID: 84895537712     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00047     Document Type: Review

References (176)

1. Balogh P, Fisi V, Szakal AK. Fibroblastic reticular cells of the peripheral lymphoid organs: unique features of a ubiquitous cell type. Mol Immunol (2008) 46:1-7. doi:10.1016/j.molimm.2008.07.014.
2. Mueller SN, Germain RN. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol (2009) 9:618-29. doi:10.1038/nri2588.
3. Fritz JH, Gommerman JL. Cytokine/stromal cell networks and lymphoid tissue environments. J Interferon Cytokine Res (2011) 31:277-89. doi:10.1089/jir.2010.0121.
4. Buettner M, Pabst R, Bode U. Stromal cell heterogeneity in lymphoid organs. Trends Immunol (2010) 31:80-6. doi:10.1016/j.it.2009.11.003.
5. Roozendaal R, Mebius RE. Stromal cell-immune cell interactions. Annu Rev Immunol (2011) 29:23-43. doi:10.1146/annurev-immunol-031210-101357.
6. Koning JJ, Mebius RE. Interdependence of stromal and immune cells for lymph node function. Trends Immunol (2012) 33:264-70. doi:10.1016/j.it.2011.10.006.
7. den Haan JM, Mebius RE, Kraal G. Stromal cells of the mouse spleen. Front Immunol (2012) 3:201. doi:10.3389/fimmu.2012.00201.
8. Malhotra D, Fletcher AL, Turley SJ. Stromal and hematopoietic cells in secondary lymphoid organs: partners in immunity. Immunol Rev (2013) 251:160-76. doi:10.1111/imr.12023.
9. Aguzzi A, Kranich J, Krautler NJ. Follicular dendritic cells: origin, phenotype, and function in health and disease. Trends Immunol (2013). doi:10.1016/j.it.2013.11.001.
10. Allen CD, Cyster JG. Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin Immunol (2008) 20:14-25. doi:10.1016/j.smim.2007.12.001.
11. El Shikh ME, Pitzalis C. Follicular dendritic cells in health and disease. Front Immunol (2012) 3:292. doi:10.3389/fimmu.2012.00292.
12. Rezk SA, Nathwani BN, Zhao X, Weiss LM. Follicular dendritic cells: origin, function, and different disease-associated patterns. Hum Pathol (2013) 44:937-50. doi:10.1016/j.humpath.2012.10.005.
13. Girard JP, Moussion C, Forster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol (2012) 12:762-73. doi:10.1038/nri3298.
14. Browning JL. Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease. Immunol Rev (2008) 223:202-20. doi:10.1111/j.1600-065X.2008.00633.x.
15. Ware CF. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev (2008) 223:186-201. doi:10.1111/j.1600-065X.2008.00629.x.
16. van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol (2010) 10:664-74. doi:10.1038/nri2832.
17. Drutskaya MS, Efimov GA, Kruglov AA, Kuprash DV, Nedospasov SA. Tumor necrosis factor, lymphotoxin and cancer. IUBMB Life (2010) 62:283-9. doi:10.1002/iub.309.
18. Zhu M, Fu YX. The role of core TNF/LIGHT family members in lymph node homeostasis and remodeling. Immunol Rev (2011) 244:75-84. doi:10.1111/j.1600-065X.2011.01061.x.
19. Remouchamps C, Boutaffala L, Ganeff C, Dejardin E. Biology and signal transduction pathways of the lymphotoxin-alphabeta/LTbetaR system. Cytokine Growth Factor Rev (2011) 22:301-10. doi:10.1016/j.cytogfr.2011.11.007.
20. Steinberg MW, Cheung TC, Ware CF. The signaling networks of the herpes virus entry mediator (TNFRSF14) in immune regulation. Immunol Rev (2011) 244:169-87. doi:10.1111/j.1600-065X.2011.01064.x.
21. Eldredge J, Berkowitz S, Corin AF, Day ES, Hayes D, Meier W, et al. Stoichiometry of LTbetaR binding to LIGHT. Biochemistry (2006) 45:10117-28. doi:10.1021/bi060210+.
22. Sudhamsu J, Yin J, Chiang EY, Starovasnik MA, Grogan JL, Hymowitz SG. Dimerization of LTbetaR by LTalpha1beta2 is necessary and sufficient for signal transduction. Proc Natl Acad Sci U S A (2013) 110:19896-901. doi:10.1073/pnas.1310838110.
23. Lukashev M, LePage D, Wilson C, Bailly V, Garber E, Lukashin A, et al. Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy. Cancer Res (2006) 66:9617-24. doi:10.1158/0008-5472.CAN-06-0217.
24. Bekiaris V, Sedy JR, Macauley MG, Rhode-Kurnow A, Ware CF. The inhibitory receptor BTLA controls gammadelta T cell homeostasis and inflammatory responses. Immunity (2013) 39:1082-94. doi:10.1016/j.immuni.2013.10.017.
25. Steinberg MW, Huang Y, Wang-Zhu Y, Ware CF, Cheroutre H, Kronenberg M. BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection. PLoS One (2013) 8:e77992. doi:10.1371/journal.pone.0077992.
26. Hashimoto T, Schlessinger D, Cui CY. Troy binding to lymphotoxin-alpha activates NF kappa B mediated transcription. Cell Cycle (2008) 7:106-11. doi:10.4161/cc.7.1.5135.
27. Bossen C, Ingold K, Tardivel A, Bodmer JL, Gaide O, Hertig S, et al. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem (2006) 281:13964-71. doi:10.1074/jbc.M601553200.
28. Togbe D, de Sousa PL, Fauconnier M, Boissay V, Fick L, Scheu S, et al. Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria. PLoS One (2008) 3:e2608. doi:10.1371/journal.pone.0002608.
29. Cuff CA, Sacca R, Ruddle NH. Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J Immunol (1999) 162:5965-72.
30. Kruglov AA, Grivennikov SI, Kuprash DV, Winsauer C, Prepens S, Seleznik GM, et al. Nonredundant function of soluble LTalpha3 produced by innate lymphoid cells in intestinal homeostasis. Science (2013) 342:1243-6. doi:10.1126/science.1243364.
31. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem (1997) 272:32401-10. doi:10.1074/jbc.272.51.32401.
32. Browning JL, Androlewicz MJ, Ware CF. Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma. J Immunol (1991) 147:1230-7.
33. Androlewicz MJ, Browning JL, Ware CF. Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. J Biol Chem (1992) 267:2542-7.
34. Young J, Yu X, Wolslegel K, Nguyen A, Kung C, Chiang E, et al. Lymphotoxin-alphabeta heterotrimers are cleaved by metalloproteinases and contribute to synovitis in rheumatoid arthritis. Cytokine (2010) 51:78-86. doi:10.1016/j.cyto.2010.03.003.
35. Satpathy AT, Briseno CG, Lee JS, Ng D, Manieri NA, Kc W, et al. Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat Immunol (2013) 14:937-48. doi:10.1038/ni.2679.
36. Spits H. Another armament in gut immunity: lymphotoxin-mediated crosstalk between innate lymphoid and dendritic cells. Cell Host Microbe (2011) 10:3-4. doi:10.1016/j.chom.2011.07.002.
37. Metzger TC, Anderson MS. Control of central and peripheral tolerance by Aire. Immunol Rev (2011) 241:89-103. doi:10.1111/j.1600-065X.2011.01008.x.
38. Ganeff C, Remouchamps C, Boutaffala L, Benezech C, Galopin G, Vandepaer S, et al. Induction of the alternative NF-kappaB pathway by lymphotoxin alphabeta (LTalphabeta) relies on internalization of LTbeta receptor. Mol Cell Biol (2011) 31:4319-34. doi:10.1128/MCB.05033-11.
39. Razani B, Reichardt AD, Cheng G. Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives. Immunol Rev (2011) 244:44-54. doi:10.1111/j.1600-065X.2011.01059.x.
40. Chiang EY, Kolumam GA, Yu X, Francesco M, Ivelja S, Peng I, et al. Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease. Nat Med (2009) 15:766-73. doi:10.1038/nm.1984.
41. Lowes KN, Croager EJ, Olynyk JK, Abraham LJ, Yeoh GC. Oval cell-mediated liver regeneration: role of cytokines and growth factors. J Gastroenterol Hepatol (2003) 18:4-12. doi:10.1046/j.1440-1746.2003.02906.x.
42. Haybaeck J, Zeller N, Wolf MJ, Weber A, Wagner U, Kurrer MO, et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell (2009) 16:295-308. doi:10.1016/j.ccr.2009.08.021.
43. Martinet L, Filleron T, Le Guellec S, Rochaix P, Garrido I, Girard JP. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin beta-producing dendritic cells in human breast cancer. J Immunol (2013) 191:2001-8. doi:10.4049/jimmunol.1300872.
44. Dhawan P, Su Y, Thu YM, Yu Y, Baugher P, Ellis DL, et al. The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells. J Biol Chem (2008) 283:15399-408. doi:10.1074/jbc.M708272200.
45. Watanabe T, Ishihara K, Hirosue A, Watanabe S, Hino S, Ojima H, et al. Higher-order chromatin regulation and differential gene expression in the human tumor necrosis factor/lymphotoxin locus in hepatocellular carcinoma cells. Mol Cell Biol (2012) 32:1529-41. doi:10.1128/MCB.06478-11.
46. Falvo JV, Jasenosky LD, Kruidenier L, Goldfeld AE. Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation. Adv Immunol (2013) 118:37-128. doi:10.1016/B978-0-12-407708-9.00002-9.
47. Subrata LS, Voon DC, Yeoh GC, Ulgiati D, Quail EA, Abraham LJ. TNF-inducible expression of lymphotoxin-beta in hepatic cells: an essential role for NF-kappaB and Ets1 transcription factors. Cytokine (2012) 60:498-504. doi:10.1016/j.cyto.2012.05.029.
48. Wicks K, Knight JC. Transcriptional repression and DNA looping associated with a novel regulatory element in the final exon of the lymphotoxin-beta gene. Genes Immun (2011) 12:126-35. doi:10.1038/gene.2010.62.
49. Jana M, Pahan K. Induction of lymphotoxin-alpha by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70. Immunology (2009) 127:312-25. doi:10.1111/j.1365-2567.2008.02985.x.
50. Seye CI, Agca Y, Agca C, Derbigny W. P2Y2 receptor-mediated lymphotoxin-alpha secretion regulates intercellular cell adhesion molecule-1 expression in vascular smooth muscle cells. J Biol Chem (2012) 287:10535-43. doi:10.1074/jbc.M111.313189.
51. Yokley BH, Selby ST, Posch PE. A stimulation-dependent alternate core promoter links lymphotoxin alpha expression with TGF-beta1 and fibroblast growth factor-7 signaling in primary human T cells. J Immunol (2013) 190:4573-84. doi:10.4049/jimmunol.1201068.
52. Heesters BA, Chatterjee P, Kim YA, Gonzalez SF, Kuligowski MP, Kirchhausen T, et al. Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation. Immunity (2013) 38:1164-75. doi:10.1016/j.immuni.2013.02.023.
53. Katakai T. Marginal reticular cells: a stromal subset directly descended from the lymphoid tissue organizer. Front Immunol (2012) 3:200. doi:10.3389/fimmu.2012.00200.
54. Chyou S, Ekland EH, Carpenter AC, Tzeng TC, Tian S, Michaud M, et al. Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J Immunol (2008) 181:3887-96. doi:10.4049/jimmunol.0902914.
55. Mionnet C, Mondor I, Jorquera A, Loosveld M, Maurizio J, Arcangeli ML, et al. Identification of a new stromal cell type involved in the regulation of inflamed B cell follicles. PLoS Biol (2013) 11:e1001672. doi:10.1371/journal.pbio.1001672.
56. Benezech C, White A, Mader E, Serre K, Parnell S, Pfeffer K, et al. Ontogeny of stromal organizer cells during lymph node development. J Immunol (2010) 184:4521-30. doi:10.4049/jimmunol.0903113.
57. Nishikawa S, Honda K, Hashi H, Yoshida H. Peyer's patch organogenesis as a programmed inflammation: a hypothetical model. Cytokine Growth Factor Rev (1998) 9:213-20. doi:10.1016/S1359-6101(98)00014-8.
58. Peduto L, Dulauroy S, Lochner M, Spath GF, Morales MA, Cumano A, et al. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J Immunol (2009) 182:5789-99. doi:10.4049/jimmunol.0803974.
59. Castagnaro L, Lenti E, Maruzzelli S, Spinardi L, Migliori E, Farinello D, et al. Nkx2-5(+)islet1(+) mesenchymal precursors generate distinct spleen stromal cell subsets and participate in restoring stromal network integrity. Immunity (2013) 38:782-91. doi:10.1016/j.immuni.2012.12.005.
60. Gonzalez M, Mackay F, Browning JL, Kosco-Vilbois MH, Noelle RJ. The sequential role of lymphotoxin and B cells in the development of splenic follicles. J Exp Med (1998) 187:997-1007. doi:10.1084/jem.187.7.997.
61. Fu YX, Huang G, Wang Y, Chaplin DD. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin alpha-dependent fashion. J Exp Med (1998) 187:1009-18. doi:10.1084/jem.187.7.1009.
62. Tumanov A, Kuprash D, Lagarkova M, Grivennikov S, Abe K, Shakhov A, et al. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity (2002) 17:239-50. doi:10.1016/S1074-7613(02)00397-7.
63. Tumanov AV, Grivennikov SI, Shakhov AN, Rybtsov SA, Koroleva EP, Takeda J, et al. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol Rev (2003) 195:106-16.
64. Krautler NJ, Kana V, Kranich J, Tian Y, Perera D, Lemm D, et al. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell (2012) 150:194-206. doi:10.1016/j.cell.2012.05.032.
65. Peault B. Are mural cells guardians of stemness? From pluri-to multipotency via vascular pericytes. Circulation (2012) 125:12-3. doi:10.1161/CIRCULATIONAHA.111.073445.
66. Dimarino AM, Caplan AI, Bonfield TL. Mesenchymal stem cells in tissue repair. Front Immunol (2013) 4:201. doi:10.3389/fimmu.2013.00201.
67. Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell (2011) 21:193-215. doi:10.1016/j.devcel.2011.07.001.
68. Myers RC, King RG, Carter RH, Justement LB. Lymphotoxin alpha1beta2 expression on B cells is required for follicular dendritic cell activation during the germinal center response. Eur J Immunol (2013) 43:348-59. doi:10.1002/eji.201242471.
69. Mackay F, Majeau GR, Lawton P, Hochman PS, Browning JL. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur J Immunol (1997) 27:2033-42. doi:10.1002/eji.1830270830.
70. Fava RA, Notidis E, Hunt J, Szanya V, Ratcliffe N, Ngam-Ek A, et al. A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J Immunol (2003) 171:115-26.
71. Gommerman JL, Mackay F, Donskoy E, Meier W, Martin P, Browning JL. Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. J Clin Invest (2002) 110:1359-69. doi:10.1172/JCI15975.
72. Mabbott NA, MacPherson GG. Prions and their lethal journey to the brain. Nat Rev Microbiol (2006) 4:201-11. doi:10.1038/nrmicro1346.
73. Gatto D, Martin SW, Bessa J, Pellicioli E, Saudan P, Hinton HJ, et al. Regulation of memory antibody levels: the role of persisting antigen versus plasma cell life span. J Immunol (2007) 178:67-76.
74. Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, et al. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med (1999) 189:403-12. doi:10.1084/jem.189.2.403.
75. Gommerman JL, Summers deLuca L. LTbetaR and CD40: working together in dendritic cells to optimize immune responses. Immunol Rev (2011) 244:85-98. doi:10.1111/j.1600-065X.2011.01056.x.
76. Wang X, Cho B, Suzuki K, Xu Y, Green JA, An J, et al. Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers. J Exp Med (2011) 208:2497-510. doi:10.1084/jem.20111449.
77. Mebius RE. Organogenesis of lymphoid tissues. Nat Rev Immunol (2003) 3:292-303. doi:10.1038/nri1054.
78. Fletcher AL, Malhotra D, Acton SE, Lukacs-Kornek V, Bellemare-Pelletier A, Curry M, et al. Reproducible isolation of lymph node stromal cells reveals site-dependent differences in fibroblastic reticular cells. Front Immunol (2011) 2:35. doi:10.3389/fimmu.2011.00035.
79. Rennert PD, James D, Mackay F, Browning JL, Hochman PS. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity (1998) 9:71-9. doi:10.1016/S1074-7613(00)80589-0.
80. Graw F, Regoes RR. Influence of the fibroblastic reticular network on cell-cell interactions in lymphoid organs. PLoS Comput Biol (2012) 8:e1002436. doi:10.1371/journal.pcbi.1002436.
81. Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, Hinz B, et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol (2007) 8:1255-65. doi:10.1038/ni1513.
82. Lukacs-Kornek V, Malhotra D, Fletcher AL, Acton SE, Elpek KG, Tayalia P, et al. Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes. Nat Immunol (2011) 12:1096-104. doi:10.1038/ni.2112.
83. Fletcher AL, Malhotra D, Turley SJ. Lymph node stroma broaden the peripheral tolerance paradigm. Trends Immunol (2011) 32:12-8. doi:10.1016/j.it.2010.11.002.
84. Siegert S, Luther SA. Positive and negative regulation of T cell responses by fibroblastic reticular cells within paracortical regions of lymph nodes. Front Immunol (2012) 3:285. doi:10.3389/fimmu.2012.00285.
85. Roozendaal R, Mebius RE, Kraal G. The conduit system of the lymph node. Int Immunol (2008) 20:1483-7. doi:10.1093/intimm/dxn110.
86. Malhotra D, Fletcher AL, Astarita J, Lukacs-Kornek V, Tayalia P, Gonzalez SF, et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol (2012) 13:499-510. doi:10.1038/ni.2262.
87. Benezech C, Mader E, Desanti G, Khan M, Nakamura K, White A, et al. Lymphotoxin-beta receptor signaling through NF-kappaB2-RelB pathway reprograms adipocyte precursors as lymph node stromal cells. Immunity (2012) 37:721-34. doi:10.1016/j.immuni.2012.06.010.
88. Tiller G, Laumen H, Fischer-Posovszky P, Finck A, Skurk T, Keuper M, et al. LIGHT (TNFSF14) inhibits adipose differentiation without affecting adipocyte metabolism. Int J Obes (Lond) (2011) 35:208-16. doi:10.1038/ijo.2010.126.
89. Liu C, Ding H, Zhu W, Jiang S, Xu J, Zou GM. LIGHT regulates the adipogenic differentiation of mesenchymal stem cells. J Cell Biochem (2013) 114:346-53. doi:10.1002/jcb.24369.
90. Chai Q, Onder L, Scandella E, Gil-Cruz C, Perez-Shibayama C, Cupovic J, et al. Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity (2013) 38:1013-24. doi:10.1016/j.immuni.2013.03.012.
91. Link A, Hardie DL, Favre S, Britschgi MR, Adams DH, Sixt M, et al. Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans. Am J Pathol (2011) 178:1662-75. doi:10.1016/j.ajpath.2010.12.039.
92. Ngo VN, Cornall RJ, Cyster JG. Splenic T zone development is B cell dependent. J Exp Med (2001) 194:1649-60. doi:10.1084/jem.194.11.1649.
93. Balogh P, Aydar Y, Tew JG, Szakal AK. Ontogeny of the follicular dendritic cell phenotype and function in the postnatal murine spleen. Cell Immunol (2001) 214:45-53. doi:10.1006/cimm.2001.1874.
94. Katakai T, Hara T, Sugai M, Gonda H, Shimizu A. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med (2004) 200:783-95. doi:10.1084/jem.20040254.
95. Mionnet C, Sanos SL, Mondor I, Jorquera A, Laugier JP, Germain RN, et al. High endothelial venules as traffic control points maintaining lymphocyte population homeostasis in lymph nodes. Blood (2011) 118:6115-22. doi:10.1182/blood-2011-07-367409.
96. Carragher D, Johal R, Button A, White A, Eliopoulos A, Jenkinson E, et al. A stroma-derived defect in NF-kappaB2-/-mice causes impaired lymph node development and lymphocyte recruitment. J Immunol (2004) 173:2271-9.
97. Drayton DL, Bonizzi G, Ying X, Liao S, Karin M, Ruddle NH. I kappa B kinase complex alpha kinase activity controls chemokine and high endothelial venule gene expression in lymph nodes and nasal-associated lymphoid tissue. J Immunol (2004) 173:6161-8.
98. Moussion C, Girard JP. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature (2011) 479:542-6. doi:10.1038/nature10540.
99. Browning JL, Allaire N, Ngam-Ek A, Notidis E, Hunt J, Perrin S, et al. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity (2005) 23:539-50. doi:10.1016/j.immuni.2005.10.002.
100. Liao S, Ruddle NH. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol (2006) 177:3369-79.
101. Rennert PD, Browning JL, Hochman PS. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int Immunol (1997) 9:1627-39. doi:10.1093/intimm/9.11.1627.
102. Alimzhanov MB, Kuprash DV, Kosco-Vilbois MH, Luz A, Turetskaya RL, Tarakhovsky A, et al. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci U S A (1997) 94:9302-7. doi:10.1073/pnas.94.17.9302.
103. Onder L, Danuser R, Scandella E, Firner S, Chai Q, Hehlgans T, et al. Endothelial cell-specific lymphotoxin-beta receptor signaling is critical for lymph node and high endothelial venule formation. J Exp Med (2013) 210:465-73. doi:10.1084/jem.20121462.
104. Tzeng TC, Chyou S, Tian S, Webster B, Carpenter AC, Guaiquil VH, et al. CD11chi dendritic cells regulate the re-establishment of vascular quiescence and stabilization after immune stimulation of lymph nodes. J Immunol (2010) 184:4247-57. doi:10.4049/jimmunol.0902914.
105. Katakai T, Suto H, Sugai M, Gonda H, Togawa A, Suematsu S, et al. Organizer-like reticular stromal cell layer common to adult secondary lymphoid organs. J Immunol (2008) 181:6189-200.
106. Vincourt JB, Jullien D, Amalric F, Girard JP. Molecular and functional characterization of SLC26A11, a sodium-independent sulfate transporter from high endothelial venules. FASEB J (2003) 17:890-2.
107. Girard JP, Baekkevold ES, Feliu J, Brandtzaeg P, Amalric F. Molecular cloning and functional analysis of SUT-1, a sulfate transporter from human high endothelial venules. Proc Natl Acad Sci U S A (1999) 96:12772-7. doi:10.1073/pnas.96.22.12772.
108. Bao X, Moseman EA, Saito H, Petryniak B, Thiriot A, Hatakeyama S, et al. Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes. Immunity (2010) 33:817-29. doi:10.1016/j.immuni.2010.10.018.
109. Czompoly T, Labadi A, Kellermayer Z, Olasz K, Arnold HH, Balogh P. Transcription factor Nkx2-3 controls the vascular identity and lymphocyte homing in the spleen. J Immunol (2011) 186:6981-9. doi:10.4049/jimmunol.1003770.
110. Guo F, Weih D, Meier E, Weih F. Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen. Blood (2007) 110:2381-9. doi:10.1182/blood-2007-02-075143.
111. Kellermayer Z, Labadi A, Czompoly T, Arnold HH, Balogh P. Absence of Nkx2-3 homeodomain transcription factor induces the formation of LYVE-1-positive endothelial cysts without lymphatic commitment in the spleen. J Histochem Cytochem (2011) 59:690-700. doi:10.1369/0022155411410061.
112. Braun A, Worbs T, Moschovakis GL, Halle S, Hoffmann K, Bolter J, et al. Afferent lymph-derived T cells and DCs use different chemokine receptor CCR7-dependent routes for entry into the lymph node and intranodal migration. Nat Immunol (2011) 12:879-87. doi:10.1038/ni.2085.
113. Pham TH, Okada T, Matloubian M, Lo CG, Cyster JG. S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity (2008) 28:122-33. doi:10.1016/j.immuni.2007.11.017.
114. Pham TH, Baluk P, Xu Y, Grigorova I, Bankovich AJ, Pappu R, et al. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J Exp Med (2010) 207:17-27. doi:10.1084/jem.20091619.
115. Mounzer RH, Svendsen OS, Baluk P, Bergman CM, Padera TP, Wiig H, et al. Lymphotoxin-alpha contributes to lymphangiogenesis. Blood (2010) 116:2173-82. doi:10.1182/blood-2009-12-256065.
116. Kumar V, Scandella E, Danuser R, Onder L, Nitschke M, Fukui Y, et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood (2010) 115:4725-33. doi:10.1182/blood-2009-10-250118.
117. Zhu M, Yang Y, Wang Y, Wang Z, Fu YX. LIGHT regulates inflamed draining lymph node hypertrophy. J Immunol (2011) 186:7156-63. doi:10.4049/jimmunol.1002097.
118. Mumprecht V, Roudnicky F, Detmar M. Inflammation-induced lymph node lymphangiogenesis is reversible. Am J Pathol (2012) 180:874-9. doi:10.1016/j.ajpath.2011.11.010.
119. Katakai T, Hara T, Lee JH, Gonda H, Sugai M, Shimizu A. A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int Immunol (2004) 16:1133-42. doi:10.1093/intimm/dxh113.
120. Chyou S, Benahmed F, Chen J, Kumar V, Tian S, Lipp M, et al. Coordinated regulation of lymph node vascular-stromal growth first by CD11c+ cells and then by T and B cells. J Immunol (2011) 187:5558-67. doi:10.4049/jimmunol.1101724.
121. Yang CY, Vogt TK, Favre S, Scarpellino L, Huang HY, Tacchini-Cottier F, et al. Trapping of naive lymphocytes triggers rapid growth and remodeling of the fibroblast network in reactive murine lymph nodes. Proc Natl Acad Sci U S A (2014) 111:109-18. doi:10.1073/pnas.1312585111.
122. Scandella E, Bolinger B, Lattmann E, Miller S, Favre S, Littman DR, et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat Immunol (2008) 9:667-75. doi:10.1038/ni.1605.
123. Mueller SN, Matloubian M, Clemens DM, Sharpe AH, Freeman GJ, Gangappa S, et al. Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection. Proc Natl Acad Sci U S A (2007) 104:15430-5. doi:10.1073/pnas.0702579104.
124. Abe J, Ueha S, Yoneyama H, Shono Y, Kurachi M, Goto A, et al. B cells regulate antibody responses through the medullary remodeling of inflamed lymph nodes. Int Immunol (2012) 24:17-27. doi:10.1093/intimm/dxr089.
125. Webster B, Ekland EH, Agle LM, Chyou S, Ruggieri R, Lu TT. Regulation of lymph node vascular growth by dendritic cells. J Exp Med (2006) 203:1903-13. doi:10.1084/jem.20052272.
126. Angeli V, Ginhoux F, Llodra J, Quemeneur L, Frenette PS, Skobe M, et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity (2006) 24:203-15. doi:10.1016/j.immuni.2006.01.003.
127. Kataru RP, Kim H, Jang C, Choi DK, Koh BI, Kim M, et al. T lymphocytes negatively regulate lymph node lymphatic vessel formation. Immunity (2011) 34:96-107. doi:10.1016/j.immuni.2010.12.016.
128. Soderberg KA, Payne GW, Sato A, Medzhitov R, Segal SS, Iwasaki A. Innate control of adaptive immunity via remodeling of lymph node feed arteriole. Proc Natl Acad Sci U S A (2005) 102:16315-20. doi:10.1073/pnas.0506190102.
129. Kumar V, Chyou S, Stein JV, Lu TT. Optical projection tomography reveals dynamics of HEV growth after immunization with protein plus CFA and features shared with HEVs in acute autoinflammatory lymphadenopathy. Front Immunol (2012) 3:282. doi:10.3389/fimmu.2012.00282.
130. Ezaki T, Baluk P, Thurston G, La Barbara A, Woo C, McDonald DM. Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am J Pathol (2001) 158:2043-55. doi:10.1016/S0002-9440(10)64676-7.
131. Anderson AO, Anderson ND. Studies on the structure and permeability of the microvasculature in normal rat lymph nodes. Am J Pathol (1975) 80:387-418.
132. Baluk P, Yao LC, Feng J, Romano T, Jung SS, Schreiter JL, et al. TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest (2009) 119:2954-64. doi:10.1172/JCI37626.
133. Chen Q, Fisher DT, Clancy KA, Gauguet JM, Wang WC, Unger E, et al. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol (2006) 7:1299-308. doi:10.1038/ni1406.
134. Mebius RE, Dowbenko D, Williams A, Fennie C, Lasky LA, Watson SR. Expression of GlyCAM-1, an endothelial ligand for L-selectin, is affected by afferent lymphatic flow. J Immunol (1993) 151:6769-76.
135. Mebius RE, Streeter PR, Michie S, Butcher EC, Weissman IL. A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4+ CD3-cells to colonize lymph nodes. Proc Natl Acad Sci U S A (1996) 93:11019-24. doi:10.1073/pnas.93.20.11019.
136. Wrobel T, Dziegiel P, Mazur G, Zabel M, Kuliczkowski K, Szuba A. LYVE-1 expression on high endothelial venules (HEVs) of lymph nodes. Lymphology (2005) 38:107-10.
137. Gordon EJ, Gale NW, Harvey NL. Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature; LYVE-1 is also expressed on embryonic blood vessels. Dev Dyn (2008) 237:1901-9. doi:10.1002/dvdy.21605.
138. Mebius RE, Streeter PR, Breve J, Duijvestijn AM, Kraal G. The influence of afferent lymphatic vessel interruption on vascular addressin expression. J Cell Biol (1991) 115:85-95. doi:10.1083/jcb.115.1.85.
139. Brand CU, Hunziker T, Braathen LR. Isolation of human skin-derived lymph: flow and output of cells following sodium lauryl sulphate-induced contact dermatitis. Arch Dermatol Res (1992) 284:123-6. doi:10.1007/BF00372702.
140. Makinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev (2005) 19:397-410. doi:10.1101/gad.330105.
141. Tan KW, Yeo KP, Wong FH, Lim HY, Khoo KL, Abastado JP, et al. Expansion of cortical and medullary sinuses restrains lymph node hypertrophy during prolonged inflammation. J Immunol (2012) 188:4065-80. doi:10.4049/jimmunol.1101854.
142. Estes JD. Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues. Immunol Rev (2013) 254:65-77. doi:10.1111/imr.12070.
143. Zeng M, Haase AT, Schacker TW. Lymphoid tissue structure and HIV-1 infection: life or death for T cells. Trends Immunol (2012) 33:306-14. doi:10.1016/j.it.2012.04.002.
144. Chyou S, Tian S, Ekland EH, Lu TT. Normalization of the lymph node T cell stromal microenvironment in lpr/lpr mice is associated with SU5416-induced reduction in autoantibodies. PLoS One (2012) 7:e32828. doi:10.1371/journal.pone.0032828.
145. Kojima M, Nakamura S, Morishita Y, Itoh H, Yoshida K, Ohno Y, et al. Reactive follicular hyperplasia in the lymph node lesions from systemic lupus erythematosus patients: a clinicopathological and immunohistological study of 21 cases. Pathol Int (2000) 50:304-12. doi:10.1046/j.1440-1827.2000.01052.x.
146. Kojima M, Motoori T, Asano S, Nakamura S. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients. Pathol Res Pract (2007) 203:423-31. doi:10.1016/j.prp.2007.03.002.
147. Masuda A, Kasajima T. Follicular dendritic cell dysfunction and disorganization of lymphoid structures in MRL/lpr mice. Lab Invest (1999) 79:849-57.
148. Hadamitzky C, Spohr H, Debertin AS, Guddat S, Tsokos M, Pabst R. Age-dependent histoarchitectural changes in human lymph nodes: an underestimated process with clinical relevance? J Anat (2010) 216:556-62. doi:10.1111/j.1469-7580.2010.01213.x.
149. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol (2006) 7:344-53. doi:10.1038/ni1330.
150. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol (2006) 6:205-17. doi:10.1038/nri1786.
151. Carragher DM, Rangel-Moreno J, Randall TD. Ectopic lymphoid tissues and local immunity. Semin Immunol (2008) 20:26-42. doi:10.1016/j.smim.2007.12.004.
152. Neyt K, Perros F, GeurtsvanKessel CH, Hammad H, Lambrecht BN. Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol (2012) 33:297-305. doi:10.1016/j.it.2012.04.006.
153. Stranford S, Ruddle NH. Follicular dendritic cells, conduits, lymphatic vessels, and high endothelial venules in tertiary lymphoid organs: parallels with lymph node stroma. Front Immunol (2012) 3:350. doi:10.3389/fimmu.2012.00350.
154. Pearson C, Uhlig HH, Powrie F. Lymphoid microenvironments and innate lymphoid cells in the gut. Trends Immunol (2012) 33:289-96. doi:10.1016/j.it.2012.04.004.
155. Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjogren's syndrome in salivary glands of non-obese diabetic mice. Arthritis Res Ther (2009) 11:R24. doi:10.1186/ar2617.
156. Fava RA, Kennedy SM, Wood SG, Bolstad AI, Bienkowska J, Papandile A, et al. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjogren's syndrome. Arthritis Res Ther (2011) 13:R182. doi:10.1186/ar3507.
157. Katakai T, Hara T, Sugai M, Gonda H, Shimizu A. Th1-biased tertiary lymphoid tissue supported by CXC chemokine ligand 13-producing stromal network in chronic lesions of autoimmune gastritis. J Immunol (2003) 171:4359-68.
158. Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol (2009) 183:7169-77. doi:10.4049/jimmunol.0901906.
159. Phuah JY, Mattila JT, Lin PL, Flynn JL. Activated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis. Am J Pathol (2012) 181:508-14. doi:10.1016/j.ajpath.2012.05.009.
160. Seleznik GM, Reding T, Romrig F, Saito Y, Mildner A, Segerer S, et al. Lymphotoxin beta receptor signaling promotes development of autoimmune pancreatitis. Gastroenterology (2012) 143:1361-74. doi:10.1053/j.gastro.2012.07.112.
161. Lochner M, Ohnmacht C, Presley L, Bruhns P, Si-Tahar M, Sawa S, et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells. J Exp Med (2011) 208:125-34. doi:10.1084/jem.20100052.
162. Luther SA, Lopez T, Bai W, Hanahan D, Cyster JG. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity (2000) 12:471-81. doi:10.1016/S1074-7613(00)80199-5.
163. López De Padilla CM, Vallejo AN, Lacomis D, McNallan K, Reed AM. Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis. Arthritis Rheum (2009) 60:1160-72. doi:10.1002/art.24411.
164. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain (2007) 130:1089-104. doi:10.1093/brain/awm038.
165. Bombardieri M, Pitzalis C. Ectopic lymphoid neogenesis and lymphoid chemokines in Sjogren's syndrome: at the interplay between chronic inflammation, autoimmunity and lymphomagenesis. Curr Pharm Biotechnol (2012) 13:1989-96. doi:10.2174/138920112802273209.
166. Lee Y, Chin RK, Christiansen P, Sun Y, Tumanov AV, Wang J, et al. Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure. Immunity (2006) 25:499-509. doi:10.1016/j.immuni.2006.06.016.
167. Kuerten S, Schickel A, Kerkloh C, Recks MS, Addicks K, Ruddle NH, et al. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response. Acta Neuropathol (2012) 124:861-73. doi:10.1007/s00401-012-1023-3.
168. Motallebzadeh R, Rehakova S, Conlon TM, Win TS, Callaghan CJ, Goddard M, et al. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. FASEB J (2012) 26:51-62. doi:10.1096/fj.11-186973.
169. Toppila S, Paavonen T, Nieminen MS, Hayry P, Renkonen R. Endothelial L-selectin ligands are likely to recruit lymphocytes into rejecting human heart transplants. Am J Pathol (1999) 155:1303-10. doi:10.1016/S0002-9440(10)65232-7.
170. Yu P, Fu YX. Targeting tumors with LIGHT to generate metastasis-clearing immunity. Cytokine Growth Factor Rev (2008) 19:285-94. doi:10.1016/j.cytogfr.2008.04.004.
171. Wolf MJ, Seleznik GM, Zeller N, Heikenwalder M. The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development. Oncogene (2010) 29:5006-18. doi:10.1038/onc.2010.260.
172. Bauer J, Namineni S, Reisinger F, Zoller J, Yuan D, Heikenwalder M. Lymphotoxin, NF-kB, and cancer: the dark side of cytokines. Dig Dis (2012) 30:453-68. doi:10.1159/000341690.
173. Bjordahl RL, Steidl C, Gascoyne RD, Ware CF. Lymphotoxin network pathways shape the tumor microenvironment. Curr Opin Immunol (2013) 25:222-9. doi:10.1016/j.coi.2013.01.001.
174. Martinet L, Le Guellec S, Filleron T, Lamant L, Meyer N, Rochaix P, et al. High endothelial venules (HEVs) in human melanoma lesions: major gateways for tumor-infiltrating lymphocytes. Oncoimmunology (2012) 1:829-39. doi:10.4161/onci.20492.
175. Fisher DT, Chen Q, Appenheimer MM, Skitzki J, Wang WC, Odunsi K, et al. Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy. Immunol Invest (2006) 35:251-77. doi:10.1080/08820130600745430.
176. Fligny C, Duffield JS. Activation of pericytes: recent insights into kidney fibrosis and microvascular rarefaction. Curr Opin Rheumatol (2013) 25:78-86. doi:10.1097/BOR.0b013e32835b656b.